In brief: research round-up Medical Physics Web (subscription) Radio-immunotherapy with the low-energy beta emitter 177Lu-DOTA-rituximab is safe and effective for lymphoma patients, according to a study from Kantonsspital Baselland and University Hospital Basel in Switzerland. The researchers evaluated the ... |
